Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Valproate and cytochromec oxidase deficiency

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Chabrol B, Mancini J, Chretien D, Rustin P, Munnich A, Pinsard N (1994) Valproate-induced hapatic failure in a case of cytochrome c oxidase deficiency. Eur J Pediatr 153:133–135

  2. 2.

    Ponchaut S, Van Hoof F, Veitch K (1992) Cytochrome aa3 depletion is the cause of the ceficient mitochondrial respiration induced by chronic valproate administration. Biochem Pharmacol 43: 644–647

  3. 3.

    Hayasaka K, Takahashi I, Kobayashi Y Iinuma K, Narisawa K, Tada K (1986) Effects of valproate on biogenesis and function of liver mitochondria. Neurology 36:351–356

  4. 4.

    Ponchaut S, Veitch K (1993) Valproate and mitochondria. Biochem Pharmacology 46:199–204

Download references

Author information

Correspondence to Sylvie Ponchaut.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ponchaut, S., Van Hoof, F. & Veitch, K. Valproate and cytochromec oxidase deficiency. Eur J Pediatr 154, 79 (1995). https://doi.org/10.1007/BF01972980

Download citation

Keywords

  • Public Health
  • Valproate
  • Cytochromec Oxidase
  • Oxidase Deficiency
  • Cytochromec Oxidase Deficiency